Literature DB >> 11238211

Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection.

M Juntunen1, P V Kirjavainen, A C Ouwehand, S J Salminen, E Isolauri.   

Abstract

The concentration of fecal mucin and the adhesion of specific probiotics and their combinations in the intestinal mucus of infants during and after rotavirus diarrhea and in healthy children were determined. Mucus was prepared from fecal samples from 20 infants during and after rotavirus diarrhea and from 10 healthy age-matched children. Mucin concentration was determined, and the adhesion of five probiotics-Lactobacillus rhamnosus GG, Lactobacillus casei Shirota, Lactobacillus paracasei F19, Lactobacillus acidophilus LA5, and Bifidobacterium lactis Bb12-and their combinations was tested in vitro. The mean concentrations of fecal mucin during and after rotavirus diarrhea, 15.2 and 14.1 mg/g, were comparable to that in healthy children, 14.9 mg/g. The adherence of probiotics ranged from 1 to 34% in healthy subjects as indicated for the following strains: L. rhamnosus GG, 34%; B. lactis Bb12, 31%; L. acidophilus LA5, 4%; L. paracasei F19, 3%; and L. casei Shirota, 1% (P = 0.0001). The distinctive pattern of probiotic adherence was not influenced by rotavirus diarrhea. The adhesion of Bb12 in the presence of GG increased from 31 to 39% in healthy infants (P = 0.018) and in episodes of diarrhea increased from 26 to 44% (P = 0.001). Rotavirus diarrhea does not decrease the production of fecal mucin or with respect to the adhesion of probiotic bacteria tested in vitro. Combination of specific probiotic strains may enhance adherence in a synergistic manner. Optimal clinical application of these interactions may offer novel therapeutic guidelines for the treatment and prevention of gastrointestinal infections.

Entities:  

Mesh:

Year:  2001        PMID: 11238211      PMCID: PMC96052          DOI: 10.1128/CDLI.8.2.293-296.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  29 in total

1.  In vivo IgA coating of anaerobic bacteria in human faeces.

Authors:  L A van der Waaij; P C Limburg; G Mesander; D van der Waaij
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

Review 2.  Uptake and transport of macromolecules by the intestine: possible role in clinical disorders (an update).

Authors:  I R Sanderson; W A Walker
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

3.  Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.

Authors:  N Lycke; J Holmgren
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

4.  The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens.

Authors:  N Lycke; U Karlsson; A Sjölander; K E Magnusson
Journal:  Scand J Immunol       Date:  1991-06       Impact factor: 3.487

5.  The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus.

Authors:  A C Ouwehand; E Isolauri; P V Kirjavainen; S Tölkko; S J Salminen
Journal:  Lett Appl Microbiol       Date:  2000-01       Impact factor: 2.858

6.  A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children.

Authors:  E Isolauri; M Juntunen; T Rautanen; P Sillanaukee; T Koivula
Journal:  Pediatrics       Date:  1991-07       Impact factor: 7.124

7.  Mucin degradation in human colon ecosystems. Fecal population densities of mucin-degrading bacteria estimated by a "most probable number" method.

Authors:  R S Miller; L C Hoskins
Journal:  Gastroenterology       Date:  1981-10       Impact factor: 22.682

8.  Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain.

Authors:  M Kaila; E Isolauri; E Soppi; E Virtanen; S Laine; H Arvilommi
Journal:  Pediatr Res       Date:  1992-08       Impact factor: 3.756

Review 9.  Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface.

Authors:  E H Beachey
Journal:  J Infect Dis       Date:  1981-03       Impact factor: 5.226

10.  Some studies of the bacterial flora associated with the mucosa of the human gastrointestinal tract.

Authors:  S L Peach; S Tabaqchali
Journal:  Nahrung       Date:  1984
View more
  40 in total

1.  Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits.

Authors:  Ingemar von Ossowski; Justus Reunanen; Reetta Satokari; Satu Vesterlund; Matti Kankainen; Heikki Huhtinen; Soile Tynkkynen; Seppo Salminen; Willem M de Vos; Airi Palva
Journal:  Appl Environ Microbiol       Date:  2010-01-29       Impact factor: 4.792

2.  Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study.

Authors:  Ruchika Mohan; Corinna Koebnick; Janko Schildt; Sabine Schmidt; Manfred Mueller; Mike Possner; Michael Radke; Michael Blaut
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

Review 3.  A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation.

Authors:  Mershen Govender; Yahya E Choonara; Pradeep Kumar; Lisa C du Toit; Sandy van Vuuren; Viness Pillay
Journal:  AAPS PharmSciTech       Date:  2013-09-25       Impact factor: 3.246

4.  Antioxidant lactobacilli could protect gingival fibroblasts against hydrogen peroxide: a preliminary in vitro study.

Authors:  Ayşegül Mendi; Belma Aslım
Journal:  Probiotics Antimicrob Proteins       Date:  2014-12       Impact factor: 4.609

5.  Modulation of the gut microbiota with antibiotic treatment suppresses whole body urea production in neonatal pigs.

Authors:  Patrycja Puiman; Barbara Stoll; Lars Mølbak; Adrianus de Bruijn; Henk Schierbeek; Mette Boye; Günther Boehm; Ingrid Renes; Johannes van Goudoever; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-11-08       Impact factor: 4.052

6.  Characterization of Functional, Safety, and Probiotic Properties of Enterococcus faecalis AG5 Isolated From Wistar Rat, Demonstrating Adherence to HCT 116 Cells and Gastrointestinal Survivability.

Authors:  Alok Kumar Mishra; Asit Ranjan Ghosh
Journal:  Probiotics Antimicrob Proteins       Date:  2018-09       Impact factor: 4.609

7.  Potential probiotic attributes of a new strain of Bacillus coagulans CGMCC 9951 isolated from healthy piglet feces.

Authors:  Shao-Bin Gu; Li-Na Zhao; Ying Wu; Shi-Chang Li; Jian-Rui Sun; Jing-Fang Huang; Dan-Dan Li
Journal:  World J Microbiol Biotechnol       Date:  2015-03-10       Impact factor: 3.312

8.  Rotavirus infection induces glycan availability to promote ileum-specific changes in the microbiome aiding rotavirus virulence.

Authors:  Melinda A Engevik; Lori D Banks; Kristen A Engevik; Alexandra L Chang-Graham; Jacob L Perry; Diane S Hutchinson; Nadim J Ajami; Joseph F Petrosino; Joseph M Hyser
Journal:  Gut Microbes       Date:  2020-05-13

9.  A dairy bacterium displays in vitro probiotic properties for the pharyngeal mucosa by antagonizing group A streptococci and modulating the immune response.

Authors:  Simone Guglielmetti; Valentina Taverniti; Mario Minuzzo; Stefania Arioli; Ivan Zanoni; Milda Stuknyte; Francesca Granucci; Matti Karp; Diego Mora
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

10.  Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?

Authors:  P V Kirjavainen; T Arvola; S J Salminen; E Isolauri
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.